GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (LSE:RENE) » Definitions » Insider Ownership

ReNeuron Group (LSE:RENE) Insider Ownership : 13.81 % (As of May. 05, 2024)


View and export this data going back to 2005. Start your Free Trial

What is ReNeuron Group Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ReNeuron Group's insider ownership is 13.81%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ReNeuron Group's Institutional Ownership is 0.69%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ReNeuron Group's Float Percentage Of Total Shares Outstanding is 0.00%.

ReNeuron Group Insider Ownership Historical Data

The historical data trend for ReNeuron Group's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Insider Ownership Chart

ReNeuron Group Historical Data

The historical data trend for ReNeuron Group can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Insider Ownership 13.81 13.81 13.81 13.82 13.82 13.82 13.82 13.82 13.81 13.81

ReNeuron Group Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

ReNeuron Group (LSE:RENE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (LSE:RENE) » Definitions » Insider Ownership
Comparable Companies
SLRX GLMD QRON ELOX APVO TSOI CNSP DRMA CWBR CPMV OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
RNUGF:USA RENE.GB:UK RQE1:Germany
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
Website
https://www.reneuron.com
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.